Can brain wave tests spot early dementia risk?

NCT ID NCT07068620

Recruiting now Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at people with cerebral small vessel disease, a common condition in older adults that can lead to stroke and dementia. Researchers will measure brain activity using EEG and test whether home-based cognitive training or mild brain stimulation can improve thinking skills. The goal is to find better ways to detect and manage early cognitive problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: home-based cognitive training and transcranial alternating current stimulation (tACS)
What this could lead to: If successful, this could identify new brain-wave markers to detect cognitive decline earlier and point toward personalized training or stimulation strategies.
What could go wrong: This is a small, early-stage observational study (80 participants) focused on biomarkers, not a treatment trial. The cognitive training and stimulation are exploratory, so real-world benefits remain uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL SMALL VESSEL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cerebral Small Vessel Diseases Cognitive Dysfunction dementia stroke disorder subjective cognitive decline

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CEREBRAL SMALL VESSEL DISEASE COGNITIVE COMPLAINT STROKE

Contacts and locations

Locations

CHU de Bordeaux, Hôpital Pellegrin, Unité Neurovasculaire
RECRUITING

Bordeaux, 33000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.